Previously, laser was considered the gold standard treatment of these patients based on the landmark Early Treatment Diabetic Retinopathy Group and on the Diabetic Retinopathy Study trials [17, 18].The advent of anti-VEGF treatment has led to a major shift in both the management and prognosis of DMO. The gene discussed is VEGFA; the disease is diabetic retinopathy.